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ABSTRACT 
Objective: The aim of this study was (1) to assess the characteristics of patients with acute poisoning who called the Belgian Poison Centre 
(BPC) and were advised to go to the hospital, (2) to identify factors associated with the type of hospital referral and (3) to estimate direct 
payer’s cost.  
Methods: Medical and financial data 2018 of BPC and financial data 2017 of Ghent University Hospital (GUH) were used. Toxic agents 
involved were categorised according to the World Health Organization ICD-10 classification. Three types of referrals were distinguished: 
referral in case of deterioration of the patient’s condition (Hosp-watchful-wait), referral to the hospital (Hosp-referral) or urgent referral to the 
hospital (Hosp-urgent-referral). Factors associated with type of recommendation for hospitalisation were identified using multivariate logistic 
regression. 
Results: 5,476 referrals were included (20.1% of all calls): 72.4% accidental poisoning, 25.3% intentional self-harm, 1.2% substance abuse, and 1.1%  
unclear intentionality. Adults accounted for 56.9%. There were 43.2% Hosp-watchful-wait cases, 48.9% Hosp-referrals and 7.9% Hosp-urgent-
referrals. In Hosp-watchful-wait cases, soaps and detergents were most frequently involved (20.5%), followed by topical agents primarily affecting 
skin, mucous membrane or ophtalmological, otorhinolaryngological and dental drugs (8.1%), and  noxious substances ingested as food (7.5%). In 
Hosp-referral cases, benzodiazepines (12.7%), antidepressants (7.9%) and antipsychotics (6.7%) were most frequently involved. In Hosp-urgent 
referral cases, the most frequent categories were benzodiazepines (15.1%), antidepressants (7.6%), and acetaminophen (7.3%). Factors associated 
with hospitalisation type were number of symptoms, intentionality, type of agent(s) involved and the advice to use antidotes (all p<0.05). Total 
estimated cost was €7,184,731.04 or €1,312.04/patient.  
Conclusion:  A considerable percentage of patients are advised by the BPC to go to the hospital and our estimate indicates considerable cost. Our 
data provide some insight into the characteristics of these patients. Further studies on the motivation and accuracy of referrals are warranted.  
Keywords: poisoning; prehospital care; cost efficiency; hospitalisations; emergency care systems. 
 
“What this paper adds” box 
Section 1: What is already known on this subject 
• Analysis of characteristics of patients referred to the hospital and agents involved for acute poisoning by poison control centres without 
distinction between the type of hospital referral. 
• Missing link between hospitalisation and estimated cost. 
Section 2: What this study adds 
• Analysis of agents involved in calls for acute poisoning to the poison control centre, categorised according to three types of hospital 
referral: referral in case of deterioration of the patient’s condition, referral to the hospital, or urgent referral to the hospital. 
• Analysis of factors estimated to be associated with the type of the poison control centre advice with regard to type of hospital referral. 
• Analysis of the estimated cost for the government and the patient. 
 
Abbreviations 
BPC: Belgian Poison Centre; FPS Health: ED: Emergency Department; Federal Public Service Health; GUH: Ghent University Hospital; Hosp-
watchful-wait: watchful waiting, referral if deterioration of situation; Hosp-referral: referral to the hospital; Hosp-urgent-referral: urgent referral 







Intoxications are an important social problem with a considerable impact on clinical workload and expenses. It is expected that an expertise 
centre in toxicology such as a poison centre will guide the patient confronted with (suspected) poisoning to the most appropriate medical care in 
an efficient, qualitative and safe way. Speed, competence and applicability are key factors during this process.  
 In 2016, 25.04% of patients who called the Belgian poison centre (BPC) with a (suspected) poisoning, were given the advice to go the 
hospital[1]. In order to check whether patients effectively followed the advice, a survey was conducted in 2016 on 404 patients who had called 
the BPC in case of a non-intentional poisoning:  97.1% confirmed to have followed the advice (author’s unpublished data, 2018).  
In this context,  a further distinction in degree of seriousness and urgency for patients recommended to go the hospital is a key factor. It is 
important to distinguish between (1) patients referred to the hospital only if symptoms or deterioration of the situation occurs, i.e. staying at 
home and watchful waiting for symptoms to occur (Hosp-watchful-wait), (2) patients referred to the hospital (Hosp-referral) and (3) patients 
urgently referred to the hospital (Hosp-urgent-referral). Literature data and our previous research indicate that hospitalisation has an important 
impact on the cost of poisonings[2-12]. The type of referral to the hospital by the poison centre is a burden to the patient (induction of anxiety, 
problems to reach the hospital, waiting times in the hospital, fear for costs,…), the emergency department (ED)  (overcrowding, less time for 
seriously ill patients,… ) and the government (cost,…). 
As far as we know, no study focused on the link between characteristics, associated factors and costs of patients with acute poisoning 
referred to the hospital by a poison centre. Therefore, the aim of this study was (1) to assess the characteristics of patients with acute poisoning 
who were advised by the BPC to go to the hospital (Hosp-watchful-wait, Hosp-referral or Hosp-urgent-referral), (2) to identify factors associated 
with the type of referral advised and (3) to calculate direct BPC cost and estimate hospital costs.  
MATERIALS AND METHODS 
We used the “Strengthening the Reporting of Observational Studies in Epidemiology” STROBE Statement as a guideline for reporting[13]. 
Study design and setting 
This observational study was set up in November 2017 to analyse all poisoning-related information files of calls to the BPC between 1 January 
2018 and 30 June 2018. The BPC is a public foundation, funded by the Federal Public Service Health (FPS Health) in the context of emergency 
medical assistance. Physicians and pharmacists give 24/7 toll-free telephone advice to lay persons and healthcare professionals in Belgium 
(11,358,357 inhabitants in 2018)[14] and the Grand Duchy of Luxembourg (602,005 inhabitants in 2018)[15] in cases of (suspected) toxic 
exposures. According to the risk assessment made, the advice given is either (1) to stay at home and/or advice on first aid, (2) to consult a 
general practitioner (3) or to go to the hospital. Patients who are advised to go to the hospital are first assessed in the emergency department 
(ED), followed by (1) discharge home, (2) observation in the 24-hours-observation unit of the ED, (3) hospitalisation or (4) admission to the 
intensive care. 
Participants 
Patients (children and adults) were included if they were advised by the BPC (1) to go to the hospital if symptoms appeared or their condition 
worsened (Hosp-watchful-wait), (2) to go to the hospital (Hosp-referral) or (3) to go urgently to the hospital (Hosp-urgent-referral).  
Phone calls from mobile intensive care unit teams were also included. In case of multiple victims, calls were only included if data were available 
at individual patient level. Requests for information were excluded. 
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Variables and data sources 
The electronic data forms filled in by the physician/pharmacist during or immediately after the call were used. This registration system contains 
information on caller and victim type, location of the caller and the victim, symptoms, circumstances, agent(s) involved, route of exposure, 
location advised for treatment and examinations proposed. Cases from the group ‘referral to the hospital’ were further categorised into Hosp-
watchful-wait, Hosp-referral or Hosp-urgent-referral. 
Cost was defined as the payer’s cost. The call to the BPC is free of charges to the caller due the financial subvention of the BPC by the 
government. The cost/call was calculated by taking 70% of the governmental subsidies divided by the total number of calls in 2017[16]. 
As there was no follow-up available in the BPC of the included patients advised to go to the hospital, the cost/admission to the hospital 
was estimated from patients with acute poisoning admitted to the emergency department (ED) of Ghent university hospital (GUH) in 2017 
(author’s unpublished data, 2018). The cost for the hospital is partly paid by the government, through contributions from the mandatory health 
and disability insurance via one of the seven health insurance funds. The part not refunded is a personal fee paid by the individual patient (or 
his/her supplementary health insurance). 
Bias 
It was not possible to follow up the individual patients after their call to the BPC. As a consequence, the BPC was not informed about the 
hospital of admission. It is therefore possible that the estimated hospitalisation cost of GUH, used in this study, is higher than in non-academic, 
regional hospitals. 
Study size 
The number of cases in the area during the study period determined the sample size. 
Quantitative variables 
Agents were based on patient report and noted in the electronic file. After the call, they were grouped according to the World Health 
Organisation (WHO) International Classification of Diseases ICD-10[17] T36-T50 (poisoning by drugs, medicaments and biological substances) 
or T51-T65 (toxic effects of substances chiefly nonmedicinal as to source). Patients who were in  contact with an agent that could not be 
categorised in T36-T65 but who were referred to the hospital were given an own code ‘700’. 
Symptoms were grouped according to the emergency registration system for hospital EDs, named UREG[18]. 
Statistical methods 
A descriptive study was performed on the variables. Categorical data were reported as a percentage frequency of occurrence. Chi-Square test and 
Fisher’s Exact Test were used. Univariate analysis was used to assess predicting variables related to the advice of the BPC concerning the 
hospital admission type. A multivariate logistic regression model was applied for the variables achieving statistical association in the univariate 
analysis (p<0.05). The step by step procedure was used to retain the variables that significantly contributed to the model. The Akaike 
Information Criterion (AIC) was used to compare the quality of the models. All analyses were performed using SPSS 25.0 (IBM®). 
Ethical considerations 
The analysis of the GUH data was approved by the Ethical Committee of GUH. The anonymous BPC data was analysed according the General 




Demographics and characteristics of the patients 
A total of 5,476 calls were included out of 27,724 calls between1 January 2018 and 30 June 2018; 56.9% of the victims were adults. Fourty-three 
percent were Hosp-watchful-wait cases, 48.9% Hosp-referral cases and 7.9% Hosp-urgent-referral cases. Fifty-two percent came from family 
members and 16.0% from the victim. Almost half of the calls (49.8%) were made between 8am and 6pm. In 20.2% of cases, the call was made 
by a medical professional. At the moment of the call, 86.4% of the victims were at home.  
Table 1. Demographic data and characteristics of 5,476 patients with suspected poisoning for whom a call was made to the BPC leading to the 
advice to go to the hospital. Categorization was performed according to the type of hospital referral and figures are presented as percentages. 
 
Total Hosp-watchful-wait Hosp-referral Hosp-urgent-referral Chi-square 
 n=5,476 n=2,368 n=2,677 n=431 
 
  % % % %   
Gender1 
    
<0.001 
Female 54.2 49.7 56.8 63.0  
Male 45.8 50.3 43.2 37.0 
 
Age 
    
<0.001 
Adult >=14y 56.9 39.0 69.3 78.2  
Child <14y 43.1 61.0 30.7 21.8 
 
Hour of the day 
    
<0.001 
8 am-6 pm 49.8 55.2 46.7 39.9 
 
6 pm- 12 pm 44.0 41.8 44.9 50.3 
 
12 pm- 8 am 6.2 3.0 8.5 9.7 
 
Language 
    
<0.001 
French 59.5 54.3 62.7 68.2  
Dutch 40.2 45.2 37.1 31.6 
 
Other 0.3 0.4 0.2 0.2 
 
Caller 
    
<0.001 
Family 52.3 67.6 41.0 38.1 
 
Victim 16.0 16.8 15.8 13.0 
 
General practitioner/physician 8.8 2.3 13.7 13.5 
 
Other medical caregiver 7.7 4.4 9.9 12.1 
 
Others 7.7 5.2 8.5 16.5  
Emergency medical dispatcher 3.7 0.6 6.2 5.3 
 
Profession other than medical 3.1 3.0 3.5 0.9  
Policeman/firefighter 0.8 0.2 1.4 0.7  
Victim location     <0.001 
Home 86.4 89.2 84.8 81.4 
 
Institute² 7.2 6.9 7.2 8.1  
Working place 2.5 1.9 3.1 1.6  
Public place 0.9 0.5 1.0 2.6 
 
Physician’s practice/ pharmacy 1.3 1.0 1.6 0.7  
Other 0.9 0.3 1.3 1.9  
Mobile intensive care unit 0.8 0.1 0.9 3.7 
 
     
 
1 Total of 5,169 calls 
2 Senior care facility, psychiatric care home, school 
Characteristics of patients and advice given 
Based on the assessment of information obtained by the physicians/pharmacists, 72.4% of calls were categorised as accidental, 25.3% as 
intentional self-harm, 1.2% as abuse of substances and in 1.1% intentionality was uncertain.  
In Hosp-watchful-wait cases 93.9% were categorised as accidental and 92.7% were single agent exposures. In 69.0%, there were no symptoms at 
the time of the call. When symptoms were present, 39.6% were dermatological, ophthalmological or otorhinolaryngological complaints. In 
Hosp-referral cases, 58.5% of referrals were accidental and 38.5% intentional self-harm cases. The most common symptoms were 
dermatological, ophthalmological or otorhinolaryngological complaints (22.0%), a change in consciousness (18.6%) and nausea or vomiting 
(11.4%). Activated charcoal or antidote administration was advised in 1.9%. 
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In Hosp-urgent-referral cases, 54.1% were categorised as intentional self-harm, 24.4% involved exposure to two or more agents and 
28.3% suffered from a change in consciousness. Calling  the mobile intensive care unit was mentioned and advised in 65.7%. Referral for 
antidote administration was advised in 3.2%. 
Table 2. Characteristics and advice given to 5,476 patients with suspected poisoning for whom a call was made to the BPC leading to the advice 
to go to the hospital. Categorization was performed according to the type of hospital referral and figures are presented as percentages. 











 n=5,476 n=2,368 n=2,677 n=431 
 
  % % % %   
Intentionality 
    
<0.001 
Accidental (unintentional) 72.4 93.9 58.5 40.1 
 
Intentional self-harm 25.3 5.1 38.5 54.1  
Substances of abuse 1.2 0.5 1.7 2.3 
 
Unclear intentionality 1.1 0.5 1.3 3.5 
 
Number of agents involved     <0.001 
1 85.4 92.7 80.5 75.6 
 
2 9.5 5.5 12.1 15.8 
 
>=3 5.1 1.8 7.4 8.6 
 
Type of agents involved 
    
<0.001 
T51-T65 48.2 60.8 59.1 64.0 
 
T36-T50 45.5 34.8 33.8 27.4 
 
T36-T50 & T51-T65 6.3 4.4 7.2 8.6  
Patient transport1     
<0.001 
Ambulance 63.3 66.7 66.8 25.7  
Mobile Intensive Care Unit (MICU) 32.6 29.6 31.5 65.7 
 
By own means 4.1 3.7 1.7 8.6 
 
Route of exposure 
    
<0.001 
Oral/oromucosal 79.1 77.2 79.4 88.2 
 
Cutaneous/eye 9.8 10.1 10.4 4.9 
 
Inhalation 6.3 6.5 6.4 4.6 
 
>1 route 2.5 4.0 1.5 0.7 
 
Other/unknown2 2.2 2.2 2.4 1.6 
 
Presenting symptoms3 
     
Dermatological, ophtalmological, 
otorhinolaryngological complaints 
25.6 39.6 22.0 13.1 0.02 
Changes in consciousness 16.5 6.5 18.6 28.3 0.393 
Nausea and/or vomiting 11.1 11.8 11.4 7.4 <0.001 
Respiratory problems 8.3 12.5 6.7 7.4 0.105 
General malaise 5.7 2.3 6.6 9.0 <0.001 
Behavioural and emotional disorders 5.2 4.7 5.6 4.4 0.053 
Other 4.7 4.4 4.1 9.0 0.287 
Tremor, coordination disorders 3.9 1.7 4.3 6.8 <0.001 
Abdominal pain 3.6 2.6 4.3 2.2 0.011 
Dizziness, vertigo 2.7 2.2 3.0 1.9 <0.001 
Headache 2.3 1.9 2.7 1.1 <0.001 
Pain in the limbs, neck, back shoulder and 
pelvic belt 
1.9 3.2 1.5 0.5 0.003 
Signs of neurological failure 1.3 0.9 1.4 1.6 <0.001 
Palpitations 1.2 0.3 1.4 1.6 <0.001 
Diarrhoea 0.8 0.9 0.9 0.0 0.956 
Wound, bite, sting 0.7 1.3 0.5 0.5 0.001 
Fever and convulsion 0.7 0.6 0.8 0.5 0.104 
Retrosternal and thoracic pain 0.5 0.3 0.7 0.0 <0.001 
External signs of bleeding or bleeding 0.5 0.1 0.6 0.3 0.003 
Life-threatening situation 0.2 0.0 0.2 0.8 <0.001 
Urinary problems 0.2 0.0 0.2 0.3 <0.001 
All types of non-specific, generalized 
symptoms 
2.3 2.1 2.3 3.3 
 
Number of symptoms present 
    
<0.001 
No symptoms 53.5 69.0 42.6 35.7 
 
1 symptom 35.3 25.8 41.7 48.3 
 
2 symptoms 8.8 4.6 12.0 12.1 
 
>= 3 symptoms 2.4 0.5 3.8 3.9 
 
Laboratory testing advised 




No 94.0 98.9 91.1 84.2 
 
Yes 6.0 1.1 8.9 15.8 
 
Medical imaging advised 
    
<0.001 
No 96.7 99.6 94.2 96.8 
 
Yes 3.3 0.4 5.8 3.2 
 
Monitoring vital signs advised 
    
<0.001 
No 92.9 98.2 89.5 84.2 
 
Yes 7.1 1.8 10.5 15.8 
 
Advice for antidotes4 
    
<0.001 
No 98.7 99.7 98.1 96.8 
 
Yes 1.3 0.3 1.9 3.2 
 
      
1 In 4,778 calls, information was missing 
2 Otic, rectal, subcuteaneous 
3 Total of 3,322 symptoms mentioned by the caller. In 53.5% no symptoms were mentioned. 
4 47.1% N-acetylcysteine, 14.3 % activated charcoal, 11.4% oxygen, 7.1% flumazenil, 4.3% glucagon, 2.9% atropine, 2.9% calcium gluconaat, 2.8% ethanol, 
1.4% deferoxamine, 1.4% digoxin antibodies,  1.4% hydroxocobalamin, 1.4% naloxone 
Agents involved 
Table 3 summarizes data on the 6,778 agents involved in the 5,476 calls. Soaps and detergents (10.5%), benzodiazepines (9.4%), corrosive 
substances (6.6%), agents primarily affecting skin, mucous membranes and ophtalmological, otorhinolaryngological and dental drugs (6.0%),  
antidepressants (5.5%) and antipsychotics (4.8%) were among the most frequently involved agents. They were followed by pesticides (3.7%), 
ethanol (3.4%) and acetaminophen (3.4%). 
In Hosp-watchful-wait cases, soaps and detergents were most frequently involved (20.5%), followed by agents primarily affecting the 
skin, mucous membrane or ophtalmological, otorhinolaryngological and dental drugs (8.1%) and by noxious substances eaten as food (7.5%). In 
Hosp-referral cases, benzodiazepines (12.7%), antidepressants (7.9%) and antipsychotics (6.7%) were the 3 most frequently involved categories. 
In Hosp-urgent-referral cases, the most frequent categories were benzodiazepines (15.1%), antidepressants (7.6%) and acetaminophen (7.3%).  
Table 3. Agents involved in calls for acute poisoning to the BPC during  which patients  were advised to go to the hospital and categorised according to the 
type of hospital referral. Percentages are presented. 
ICD-
10 



















  % % % %  
T42 Anti-epileptic, sedative-hypnotic, 
antiparkinsonism drugs 
11.6 5.4 15.0 18.8 <0.001 
T42.4 Benzodiazepines 9.4 3.5 12.7 15.1 <0.001 
  Anti-epileptics 1.5 1.3 1.4 2.4 0.053 
T43 Psychotropic drugs, NEC 11.6 4.3 16.3 16.0 <0.001 
  Antidepressants 5.5 1.8 7.9 7.6 <0.001 
  Antipyschotics 4.8 1.8 6.7 6.8 <0.001 
  Psychostimulants 1.1 0.6 1.4 1.2 0.003 
T55 Soaps and detergents 10.5 20.5 4.6 1.7 <0.001 
T65 Other and unspecified substances 7.6 9.6 6.6 4.9 0.001 
T65.2 Tobacco and nicotine 0.9 1.0 0.8 0.8 0.977 
T65.6 Paints and dyes, not elsewhere classified 0.1 0.3 0.1 0.2 0.12 
T39 Nonopioid analgesics, antipyretics, 
antirheumatics 
6.9 2.9 9.0 11.7 <0.001 
T39.1 Paracetamol 3.4 0.8 4.6 7.3 <0.001 
T39.3 Other nonsteroidal anti-inflammatory drugs 
[NSAID] 
2.9 1.6 3.8 3.6 <0.001 
T54 Corrosive substances 6.6 7.2 6.4 4.8 0.271 
T54.3 Corrosive alkalis and alkali-like substances 3.7 4.1 3.5 2.9 0.816 
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T54.2 Corrosive acids and acid-like substances 1.8 2.1 1.8 1.0 0.471 
T49 Agents primarily affecting skin, mucous 
membrane and ophthalmological, 
otorhinolaryngological and dental drugs 
6.0 8.1 4.7 4.4 0.003 
T51 Alcohol 4.3 2.9 4.8 7.1 <0.001 
T51.0 Ethanol 3.4 1.4 4.3 6.3 <0.001 
T62 Noxious substances eaten as food 4.2 7.5 2.3 1.5 <0.001 
T62.2 Ingested berries 2.6 4.7 1.3 1.0 <0.001 
T62.0 Ingested mushrooms 0.4 0.8 0.2 0.0 0.001 
T60 Pesticides 3.7 5.3 2.6 2.9 0.04 
T40 Narcotics and psychodysleptics 
(hallucinogens) 
3.6 1.5 4.8 5.9 <0.001 
T40.2 Other opioids 2.5 1.2 3.2 4.2 <0.001 
T40.5 Cocaine 0.3 0.1 0.4 0.3 0.015 
T40.7 Cannabis (derivatives) 0.3 0.2 0.4 0.2 0.233 
T40.8 Lysergic acid diethylamide [LSD] 0.04 0.0 0.1 0.0 0.416 
T40.1 Heroin 0.01 0.0 0.03 0.0 1 
T46 Agents primarily affecting the 
cardiovascular system 
3.6 2.5 4.3 4.6 <0.001 
  Beta-blockers 1.4 0.9 1.8 1.7 0.001 
T52 Organic solvents 2.8 4.3 1.9 1.2 <0.001 
T50 Diuretics and unspecified drugs, 
medicaments and biological substances 
2.7 3.3 2.2 2.7 0.238 
T47 Agents primarily affecting the 
gastrointestinal system 
2.4 2.7 2.2 2.0 0.091 
T45 Primarily systemic and haematological 
agents, NEC 
2.0 1.2 2.4 2.7 <0.001 
T48 Drugs acting on smooth and skeletal 
muscles and respiratory system 
2.0 2.5 1.9 0.8 0.113 
7002 Other 1.9 3.5 1.0 0.5 <0.001 
T36 Systemic antibiotics 1.5 0.8 2.0 1.4 <0.001 
T38 Hormones and their synthetic substitutes 
and antagonists, NEC 
1.3 1.0 1.5 0.7 0.068 
T63 Contact with venomous animals 0.7 0.9 0.6 0.5 0.646 
T59 Other gases, fumes and vapours 0.6 0.7 0.4 1.2 0.055 
T44 Drugs primarily affecting the autonomic 
nervous system 
0.5 0.3 0.6 0.5 0.102 
T58 Carbon monoxide 0.5 0.2 0.7 0.3 0.005 
T37 Other systemic anti-infectives and 
antiparasitics 
0.3 0.2 0.3 0.3 0.196 
T53 Halogen derivative of aliphatic and 
aromatic hydrocarbons 
0.2 0.2 0.3 0.0 0.213 
T61 Noxious substances eaten as seafood 0.2 0.2 0.2 0.3 0.599 
T41 Anaesthetics and therapeutic gases 0.1 0.1 0.1 0.3 0.196 
T56 Metals 0.1 0.2 0.0 0.0 0.359 
T57 Other inorganic substances 0.01 0.0 0.03 0.0 1 
 
1  The main ICD-10-categories are given  in bold and represent all involved agents in each category. The subcategories - not in bold - represent the most 
frequently involved agents out of the main categories. 
2 Under the code named 700 (not an ICD-10-code) we collected items like eye contour products, isolation materials, medical devices, water not suitable for 
human consumption, toys and foreign objects, inks, polymer compounds, weapons, lighting products and adhesives. 
Factors associated with type of referral for hospitalisation 
Table 4 shows the results of the univariate (unadjusted OR) and multivariate (adjusted OR) analysis performed to identify the factors associated 
with the advice by type of referral for hospitalisation. The Hosp-watchful-wait advice was used as reference. In the univariate analysis, age, 
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gender, time of the call, language of the caller, location of the victim, number of symptoms present, intentionality, type of transport, number of 
agents, number of symptoms, examinations, use of antidotes and type of agents were significantly associated with referral type of hospitalisation 
(all p<0.05). In the multivariate analysis, number of symptoms present at the time of the call to the  BPC, intentionality, type of agents involved 
and administration of antidotes advised (p<0.05) were significantly associated with referral type of hospitalisation. 
The estimated odds of being admitted to Hosp-referral or Hosp-urgent-referral versus Hosp-watchful-wait was significantly higher with 
the increasing number of symptoms. Substances of abuse, unclear intentionality and intentional self-harm were also associated with higher 
estimated odds of being categorised to Hosp-referral or Hosp-urgent-referral. The estimated odds for Hosp-urgent-referral versus Hosp-watchful-
wait was more than 20 times higher in case of intentional self-harm compared to accidental cases. The estimated odds for Hosp-referral or Hosp-
urgent-referral versus Hosp-watchful-wait was more than two times higher for the categories T36-T50 compared to the categories T51-T65. 
Table 4: Univariate (unadjusted OR) and multivariate (adjusted OR) analysis of factors possibly associated with the type of BPC advice with regard to type of 
hospital referral as compared with Hosp-watchful-wait used as the reference. The odds ratio and confidence interval are presented. 
 Hosp-referral
1 Hosp-urgent-referral1 
 UNIVARIATE MULTIVARIATE UNIVARIATE MULTIVARIATE 
  OR2 (CI3) OR2 (CI3) OR2 (CI3) OR2 (CI3) 
Number of symptoms present     
>= 3 symptoms 11.14 (6.22-19.95)** 13.82 (7.59-25.18)** 13.88 (6.62-29.12)** 18.28 (8.45-39.56)** 
2 symptoms 4.19 (3.33-5.26)** 5.35 (4.18-6.86)** 5.02 (3.47-7.26)** 6.80 (4.59-10.08)** 
1 symptom 2.62 (2.32-2.97)** 3.23 (2.80-3.73)** 3.62 (2.88-4.55)** 4.56 (3.56-5.85)** 
No symptoms Ref Ref Ref Ref 
Intentionality     
Intentional self-harm 12.08 (9.90-14.74)** 9.81 (7.90-12.17)** 24.76 (18.92-32.38)** 20.54 (15.17-27.81)** 
Undetermined intentionality 4.14 (2.14-8.00)** 3.92 (1.97-7.82)** 16.07 (7.41-34.87)** 15.37 (6.84-34.57)** 
Substances of abuse 5.81 (2.99-11.26)** 2.74 (1.37-5.49)* 11.69 (4.90-27.90)** 5.16 (2.09-12.71)** 
Accidental (unintentional) Ref Ref Ref Ref 
Type of agents     
T36-T50 & T51-T65 2.71 (2.12-3.47)** 1.06 (0.78-1.43) 4.01 (2.64-6.07)** 0.97 (0.60-1.58) 
T36-T504 3.28 (2.91-3.69)** 2.35 (2.04-2.70)** 4.38 (3.47-5.53)** 2.32 (1.76-3.06)** 
T51-T655 Ref Ref Ref Ref 
Antidotes advised     
Yes 7.49 (3.21-17.51)** 6.98 (2.88-16.92)** 13.22 (5.05-34.59)** 13.00 (4.69-36.01)** 
No Ref Ref Ref Ref 
 
1 Reference category = Hosp-watchful-wait 
2 OR: Odds ratio 
3 CI: Confidence interval  
4 T36-T50: poisoning by drugs, medicaments and biological substances 
5T51-T65: toxic effects of substances chiefly nonmedicinal as to source 
Significance level: * p<0.05; ** p<0.001 
 
Cost 
Since we do not dispose of data on the fate of BPC patients, we used the cost/admission to GUH from patients with acute poisoning. The mean 
payer’s cost for poisoned patients in GUH 2017 (whole episode) was €1,287.1 (95%CI 1,030.0-1,329.7), of which 95.7% paid by the 
government via the insurance and 4.3% by the patient.. The mean payer’s cost for the government in case of a call to the BPC was €24.9 
(author’s unpublished data, 2018). Extrapolating this cost to the 5,476 included cases in this study and assuming that each patient advised to go 
to the hospital actually did so, the estimated cost is €7,184.731.0 ((5,476 cases x € 1,287.1)+(5,476 cases x €24.9)) or €1,312.0 per patient. The 
estimated cost for the government is €6,878,458.4 (5,476 cases x 1,231.2)+(5,476 cases x €24.9) or a mean cost of €1,256.1 per patient and the 
cost for the patient is €306,272.7 (5,476 cases x 55.9) or a mean cost of €55.9. If we assume that only Hosp-referral and Hosp-urgent-referral 
patients actually went to the hospital (not the Hosp-watchful-wait patients) the total cost is €4,136,878.2 ((3,108 cases x 1,287.1)+(3,108 cases x 
€24.9)+(2,368 cases x €24.9)) or €755.5 per case for both government and patient (personal fee). 
DISCUSSION 
Our study aimed to analyse data between January and June 2018 of patients calling the BPC in case of (suspected) poisoning and advised to go 
to the hospital.  Factors associated with the type of recommendation for hospitalisation were identified, and payer’s cost was estimated on the 
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basis of GUH data.  
Analysing the intentionality of children and adults referred to the hospital (only Hosp-referral and Hosp-urgent-referral), 56.0% was 
categorised as accidental and 40.6% as intentional self-harm.The high percentage of accidental cases can be explained by the inclusion of 
children: accidental cases decreased to 42.1% and intentional self-harm cases increased to 53.6% among adults.  
A link can be found between the involved agents in adults and the higher percentage for intentional self-harm cases. In adults, agents 
categorised in T36-T50 (medicinal agents) were most commonly used: benzodiazepines (13.4%), antidepressants (8.0%), antipsychotics (6.2%), 
acetaminophen (3.8%) and NSAIDs (3.0%).  
In children, agents categorised in T51-T65 (non-medicinal agents) were frequently involved: soaps and detergents (21.4%), agents 
primarily affecting skin, mucous membrane and ophtalmological, otorhinolaryngological and dental drugs (10.9%) and noxious substances eaten 
as food (7.1%, of which 4.5% ingested berries). NSAIDs and acetaminophen accounted for 2.8% and 2.7% respectively. 
The low score of ethanol (4.8%) among adult callers is remarkable compared to the ethanol scores in hospitals. In unpublished data of 
poisonings in GUH [19], ethanol was used in 81.1% of the admissions as a single agent and in 18.9% as concomitant substance. The low score in 
our study is not surprising, as the BPC calltakers can not physically evaluate the callers which may deny their ethanol consumption. Another 
reason could be that patients do not mention spontaneously their use of ethanol, because ethanol alone is probably not often a reason to call the 
BPC, as the population is familiar with the effect of ethanol.  
In the multivariate analysis, number of symptoms, intentionality, type of agents involved and administration of antidotes advised were 
factors significantly associated with the referral type.  A higher number of symptoms present during the call was associated with a higher 
estimated odds for Hosp-referral or Hosp-urgent-referral, which is logical as the presence of multiple symptoms is an indication of severity.  In 
cases of unclear intentionality, the higher odds for Hosp-referral and Hosp-urgent-referral compared with accidental cases may be explained by 
the fact that the call-taker did not want to take any risk if he/she could not determine definitely the intentionality of the patient or if  there was a 
concern for psychosocial help. If agents T36-T50 (medicinal agents) were involved, the odds for Hosp-referral and Hosp-urgent-referral were 
more than two times higher compared with agents T51-T65 (non-medicinal agents). This can be explained by the high percentage of, amongst 
others, soaps and detergents (with a low toxicity risk) in the category Hosp-watchful-wait (20.5%) versus only 4.6% and 1.7% in Hosp-referral 
and Hosp-urgent-referral cases respectively. The need for antidotes was also a factor more frequently leading to Hosp-referral and Hosp-urgent-
referral given that antidotes are an indication of the severity of poisoning and have to be administered in the hospital obviously. 
Articles about factors that may be associated with the referral of patients from a pre-hospital situation to the hospital are rare. Woon Yon 
Kwon[20] developed a triage method to prevent unnecessary ED visits of out-of-hospital poisoned patients. He designed a triage protocol for 
out-of-hospital-toxicity-positive patients to determine a low- and high-risk group. His protocol consisted of five factors, ranked according to the 
height of the odds ratio: (1) minimally toxic substances, (2) unintentional exposures (3) without symptoms or signs (4) without pre-existing 
medical problems, current medication, pregnancy, or breast-feeding and (5) safe environment & observation possible. The three most important 
factors mentioned by Woon Yong Kwon correspond to those we found to be associated with type of referral: agents involved, intentionality and 
symptoms. 
The mean payer’s cost per admission for poisoned patients in GUH 2017 (whole episode) was €1,287.1.  It was important to make a 
distinction between patients advised to go to the hospital under certain conditions (43.2%) and those referred (48.9%) or urgently referred to the 
hospital (7.9%). Analysing the characteristics of Hosp-watchful-wait patients (93.9% accidental, 92.7% single agent exposures, in 69.0% no 
symptoms at the time of the call), we assume that only a small part of the Hosp-watchful-wait patients went effectively to the hospital after the 
BPC call. As the average estimated cost for a patient who goes to the hospital with a poisoning problem is €1,287.1, versus €24.9 for a call to the 
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BPC, every patient who did not go to the hospital, reassured by the advice of the BPC, meant an important saving for the government and the 
patient and also helped to avoid overcrowding of the ED. 
Strengths, limitations and generalisability 
In this study, we used ICD-10 as categorisation tool. BPC experts note the name(s) of the agent(s) involved in the electronic file, which is 
then linked to ICD-10 codes. This ensures that the original agent(s) behind the ICD-10 code(s) can always be consulted in the original file. This 
can be a response to the limitation, described by different authors, namely the frequent use of  non-specific ICD-10 codes and the significantly 
underestimated incidence of drug overdose for any specific drug[20,21].  We think that the use of a clear and international standard allows the 
scientific community to compare and share data in a consistent and standard way and may be a first step in the development of a template for 
uniform data reporting in order to facilitate international comparison between organisations.  Furthermore, the WHO took the initiative to 
respond to the limitations of ICD-10 by introducting a webplatform facilitating the preparation of  ICD-11[22] .  
A second limitation of our study is that we could not evaluate the validity of the referrals in function of the quality of care as it was not 
possible to do a follow-up.  
Insight into characteristics for type of referral by the BPC can give information on the decision process. These data can be used in further 
studies using hospitalisation data to assess the quality of these referrals. This is important as payer’s cost estimates showed that patients who are 
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